Table 2.
Analysis of in vitro maturation (IVM) and fertilization (IVF), after oocyte culturing in experimental and control groups
| Stages of development | Groups | Stages of development | Groups | ||||
|---|---|---|---|---|---|---|---|
| 96 hours after IVF | MII | 48 hours after IVF | 96 hours after IVF | MII | 48 hours after IVF | ||
| 21.6 ± 1 | 37.6 ± 1.1 | 67.3 ± 2 | Control (n=131) | 21.62 ± 1 | 37.6 ± 1.1 | 67.3 ± 2 | Control (n=131) |
| 5.5 ± 0.3a, b | 18.37 ± 0.4a | 37.87 ± 0.9a | Exp IV 50 μL MEHP (n=107) | 8.6 ± 0.3a | 20.37 ± 0.7a | 41.87 ± 1a | Exp I 50 μL DEHP (n=101) |
| 2.5 ± 0.3a, c, e | 10.6 ± 0.4a, c, e | 27.62 ± 0.9a, c, e | Exp V 100 μL MEHP (n=114) | 5.2 ± 0.3a, b | 14.12 ± 0.3a, b | 36.22 ± 1a | Exp II 100 μL DEHP (n=112) |
| 0.8 ± 0.2a, d, e | 6.7 ± 0.3a, e, f | 19 ± 0.01a, e, f | Exp VI 200 μL MEHP (n=124) | 1.3 ± 0.3a, b, c | 8.6 ± 0.5a, b, c | 26.5 ± 0.8a, b, c | Exp III 200 μL DEHP (n=119) |
Exp; Experiment, a; Significant differences with control group, P<0.05, b; Significant differences with experimental group I in the same column and row, P<0.05, c; Significant difference with experimental group II in the same column and row, P<0.05, d; Significant difference with experimental group III in the same column and row, P<0.05, e; Significant difference with experimental group IV in the same column and row, P<0.05, f; Significant difference with experimental group V in the same column and row, P<0.05, MEHP; Mono-(2-ethylhexyl) phthalate and DEHP; Di-(2-ethylhexyl) phthalat.